Key result
Simulated ischemia increases membrane damage and reduces viability in human iPSC-derived cardiomyocytes.
Why the study?
The physiology of the human heart differs significantly from rodent models commonly used to study ischemic heart disease, necessitating a human cell-based model.
Population
Cardiomyocytes differentiated from human induced pluripotent stem cells
Comparison
Ischemic conditioning (2% oxygen, 0 mg/ml glucose, 0% fetal bovine serum) vs control conditions
Design
Preclinical experimental study
Authors
Loading...
Provides hiPSC-CM ischemia model for research; leaves open clinical translation pending in vivo validation.
An optimized in vitro model of ischemic heart disease using hiPS-CMs successfully replicates key features of in vivo ischemia, providing a platform for future research.
Wang et al. (2019) studied Ischemic heart disease. Ischemic conditions (2% oxygen, 0 mg/ml glucose, 0% fetal bovine serum) was evaluated on Cellular damage (membrane damage, viability, contractility, IL-8 mRNA expression). Exposure of human induced pluripotent stem cell-derived cardiomyocytes to 2% oxygen, 0 mg/ml glucose, and 0% fetal bovine serum increased membrane damage and decreased cellular viability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: